Global Health Gains: How Rising Healthy Life Expectancy Drives Research
Between 2000 and 2019, global healthy life expectancy at birth (HALE) rose by approximately 5.3 years according to WHO global estimates, representing one of the more significant improvements in population health recorded in modern epidemiology. Then COVID-19 reversed nearly a decade of that progress within two years, dropping global HALE to 61.9 years by 2021, back to where it stood in 2012.
WHO’s World Health Statistics 2025 report documents a partial recovery by 2024, with an estimated 1.4 billion more people living healthier lives by the end of that year, while also warning that overall progress is under threat and urgent global action is needed to recover what the pandemic erased. For healthcare strategists and public health analysts, the direction of the recovery and the structural drivers behind it are now the central research questions.
Rising Healthy Life Expectancy
The HALE number is the right number to track, and the gap between it and total life expectancy is where the most consequential research questions currently live.
WHO Data Trends
The long-run trajectory of HALE tells a broadly positive story interrupted by a significant shock. WHO’s 2024 statistics report documents that global life expectancy fell 1.8 years to 71.4 years between 2019 and 2021, and HALE fell 1.5 years to 61.9 years over the same period.
PAHO data shows a modest regional gain in HALE over the past two decades, interrupted sharply during the acute COVID-19 phase in 2020 and 2021. The 2025 WHO report attributes the recovery in healthy-life gains specifically to reductions in tobacco use, improvements in air quality, and better access to water, hygiene, and sanitation.
More Years in Full Health
The trajectory before the pandemic established something worth holding on to: populations in many parts of the world were not just living longer but adding years in relatively good health.
McKinsey Health Institute analysis estimates that age-related diseases and conditions account for approximately 633 million disability-adjusted life years annually, roughly 2.5 times the burden of oncology, which quantifies the scale of the gap between what healthy longevity could look like and what it currently does.
Healthspan research is a fast-growing field, and the scientific community’s focus has shifted from extending total life duration toward compressing the period of ill-health at the end of life, which is a meaningfully different research question.
Mixed Progress: The HALE Gap
A 2024 analysis published in JAMA Network Open, covering all 183 WHO member states, found that the average gap between total life expectancy and healthy life expectancy stands at 9.6 years and has widened by 13 percent since 2000, rising from 8.5 years at the start of the century.
This means that on average, people are gaining years of life but those additional years are disproportionately spent in poor health rather than in full function. The research challenge this creates is not simply about extending healthspan at a population level. It is about understanding which interventions, behaviours, environments, and healthcare system characteristics determine on which side of that nearly decade-long gap a given population falls.
Implications for Healthcare Research
The HALE gap is not an abstract policy problem. It is the source of a specific set of research demands that require specialist expertise to answer rigorously.
Focus on Chronic Disease and Aging
Age-related NCDs account for a large share of the global disease burden, with cardiovascular disease, cancer, diabetes, musculoskeletal conditions, and neurological decline contributing the most to the gap between years lived and years lived in good health.
Research into prevention, early detection, and disease modification in these categories requires access to clinicians managing these conditions over extended patient histories, health economists modelling the cost-effectiveness of different intervention points, and epidemiologists who can interpret the population-level evidence base. These are not profiles that self-assemble in general research panels.
Preventive Health and Wellness
The 2025 WHO report’s finding that HALE recovery was driven by tobacco reduction, air quality improvements, and sanitation gains points toward the structural truth that most of the modifiable determinants of healthy life expectancy sit outside the clinical system.
McKinsey Health Institute research has been built around the goal of helping humanity add six years of higher-quality life per person over the next decade, a target that requires addressing health determinants across nutrition, environment, behaviour, and healthcare access simultaneously. The research agenda around HALE improvement therefore spans behavioural science, environmental health, urban planning, and workforce health in ways that cannot be addressed from within a single clinical discipline.
Health Equity and Policy
The regional divergence in HALE gains is where the SDG alignment sits, and it is also where research design complexity is highest. WHO’s 2024 data shows that the Americas and South-East Asia experienced the largest life expectancy and HALE losses during the pandemic, with impacts materially larger than those seen in Europe and the Western Pacific.
Understanding what determined those differences, and what recovery trajectories will look like by region, requires public health analysts, health system specialists, and policy researchers with direct knowledge of the systems in question, not generalist commentary from practitioners whose experience is concentrated in high-income settings.
Emerging Research Areas
The HALE gap has generated a specific research frontier that the science is now actively working to close.
Longitudinal Health Studies
Tracking population cohorts over extended periods is the gold standard methodology for understanding how health trajectories evolve in response to behavioural, environmental, clinical, and socioeconomic factors.
This kind of research requires specialists who have managed longitudinal dataset design, who understand the attrition and survivorship bias challenges that distort long-run health data, and who can interpret the interaction effects between multiple health determinants over time. In Gattaca, the premise is that genetic sequencing at birth determines which health trajectory you are on. The real research question the HALE data is asking is considerably more complex: which combination of factors determines which decade of your life is spent in poor health, and whether that decade can be moved or compressed.
Comparative Health Economics
As health systems and private markets invest increasing resources in prevention, longevity, and age-related disease management, the economic question of whether specific interventions are cost-effective relative to conventional disease management is becoming a priority for payers, governments, and strategy teams across sectors. Health economists who can model the downstream savings from preventing or delaying a year of disability against the upstream cost of the intervention that achieved it are a specialist profile with a small qualifying population and significant demand from multiple client types simultaneously.
McKinsey estimates that improving population health could unlock significant economic value, but the research that validates or challenges that estimate at the programme level requires practitioners working at the intersection of clinical evidence and economic modelling.
Tech Solutions: Digital Health and AI in Diagnosis
The application of AI to diagnostic imaging, clinical note synthesis, disease risk prediction, and population health monitoring is now operational in a growing number of health systems. For healthcare strategy researchers and public health analysts, the research questions have shifted from whether AI can perform these tasks to which patient populations benefit, what the false-positive and false-negative profiles look like at scale, and what the health equity implications are when AI tools trained on data from high-income health systems are applied in under-resourced settings.
These questions require technical clinical specialists, AI methodologists, and equity-focused health researchers working in combination, a cross-disciplinary expert profile that no panel database is currently structured to supply.
Role of Experts in Health Research
The HALE agenda is where the methodological argument for cross-disciplinary expert recruitment is strongest, because the questions are by definition too wide for any single discipline to answer.
Epidemiologists and Demographers
Interpreting HALE trends and translating them into actionable research priorities requires epidemiologists and demographers who understand the methodological limitations of HALE as a measure, the assumptions embedded in disability-adjusted life year calculations, and the compositional effects that make cross-country HALE comparisons more complex than headline figures suggest.
These practitioners are working at the intersection of public health data, health system performance research, and demographic modelling, and they are sourced through academic networks, public health agencies, and research institutions rather than professional directories that panel databases can access. The 9.6-year healthspan gap documented in the JAMA analysis is a number that becomes analytically useful only when an epidemiologist with the right methodological background explains what is driving the variance around that mean at the country and regional level.
Cross-Disciplinary Input
The most important health research outputs on the HALE question will not come from any single discipline working in isolation. The combination of biogerontologists who understand the biology of cellular ageing, behavioural scientists who can model lifestyle intervention uptake, clinical specialists in the NCD categories that drive most HALE loss, health economists modelling intervention cost-effectiveness, and public health policy researchers who understand implementation in different health system contexts is what makes a research programme on healthspan genuinely informative rather than descriptive. Assembling that combination against a specific research brief is a custom expert recruitment exercise, not a panel field deployment.
The Gap Between Lifespan and Healthspan Is the Frontier
The HALE data describes a world in which people are living longer while spending a disproportionate and widening portion of those additional years in poor health, and in which the determinants of that distribution are complex, cross-sectoral, and highly variable by geography, socioeconomic context, and health system design.
That description is also a map of where the most important and most difficult research questions currently sit. The experts capable of answering those questions are working in epidemiology, demographic modelling, health economics, clinical subspecialties, behavioural science, and digital health, often at the intersection of two or more of those fields simultaneously. Finding them, verifying their specific expertise, and structuring their input around a research brief that needs all of them in combination is the challenge that the HALE agenda places directly in front of healthcare research teams right now.
If your next study needs that kind of cross-disciplinary combination against a specific brief, Nexus Expert Research can help assemble it.
